Inossia AB

medical devices

About

Inossia AB is a Swedish medical technology company based in Stockholm, founded in 2013. The company specializes in innovative biomaterials aimed at improving bone health, particularly for osteoporosis-related fractures and degenerative spine conditions. Inossia has developed a patented softener for bone cements that enhances traditional materials to better match the mechanical properties of osteoporotic bone. This technology aims to improve treatment outcomes by reducing the risk of adjacent fractures and vertebral collapse. The company's soft bone cement technology is designed for vertebral augmentation procedures, such as vertebroplasty and kyphoplasty. It provides immediate pain relief and helps preserve patient mobility. Inossia is actively engaged in clinical studies to support regulatory applications in the US and EU, having received the US FDA Breakthrough Device Designation for its innovative solutions. The company targets healthcare providers specializing in spine care and osteoporosis treatment, focusing on improving outcomes for patients with osteoporotic vertebral fractures.

Technologies

Outlook Microsoft Office 365 Apache Mobile Friendly WordPress.org Google Tag Manager Google Font API Varnish Circle Remote AI Android React Native Node.js

Keywords

medical devices bone cement soft cement vertebroplasty kyphoplasty discoplasty spine medical equipment manufacturing spine health innovation services medical device development spine surgery multi-center clinical trial orthopedics healthcare cost savings vertebral fracture treatment product development b2b medical innovation spine biomechanics adaptation spinal fracture soft cement vertebral augmentation bone cement elasticity fracture management fracture risk reduction spinal fracture prevention active aging vertebral fracture prevention bone cement softener spine fracture innovation

Location

64 Kungsgatan, Stockholm, Stockholm County, Sweden, 111 22

Related Companies

Companies in the same industry